Sunshine Biopharma (SBFM) Tax Provisions (2022 - 2025)
Sunshine Biopharma's (SBFM) quarterly Tax Provisions came in at $431298.0 in Q4 2025, up 184.07% on a YoY basis from $151829.2 in Q4 2024, and up 413.81% quarter-over-quarter from -$137438.0 in Q3 2025.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Tax Provisions (2022 - 2025) Analysis & Trends
Sunshine Biopharma (SBFM) has reported Tax Provisions for 4 consecutive years, with $431298.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Tax Provisions rose 184.07% year-over-year to $431298.0; the trailing twelve-month figure through Jun 2026 stood at $293860.0 (up 153.71% YoY), and the FY2025 full-year result was $44533.0, up 118.96% from the prior year.
- Tax Provisions advanced to $431298.0 in Q4 2025 per SBFM's latest filing, from -$137438.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $431298.0 in Q4 2025 and bottomed at -$513035.0 in Q4 2024.
- Historically, Tax Provisions has averaged $6228.8 across 4 years, with a median of $52586.0 in 2023.
- The widest YoY moves for Tax Provisions: up 309.27% in 2024, down 492.0% in 2024.
- Over 4 years, Tax Provisions stood at $233304.0 in 2022, then decreased by 21.9% to $182213.0 in 2023, then slumped by 381.56% to -$513035.0 in 2024, then jumped by 184.07% to $431298.0 in 2025.
- According to Business Quant data, Tax Provisions over the past three periods registered $431298.0, -$137438.0, and -$209166.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.61 Bn | 38.95 Bn | 2.15 Bn | 121.00 Mn |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | 54.80 Mn |
| 3 | Dr Reddys Laboratories | 9.85 Bn | 9.68 Bn | 396.53 Mn | 12.44 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | 1.38 Mn |
| 5 | Bausch Health Companies | 2.36 Bn | 518.87 Mn | 2.10 Bn | 88.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -59,000.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 12.40 Mn |
| 8 | Amphastar Pharmaceuticals | 994.21 Mn | 704.09 Mn | 93.47 Mn | 8.20 Mn |
| 9 | Fennec Pharmaceuticals | 405.56 Mn | 364.31 Mn | 17.15 Mn | 42,000.00 |
| 10 | Sunshine Biopharma | 1.56 Mn | -12.19 Mn | 2.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 431,298.00 |
| Sep 30, 2025 | -137,438.00 |
| Jun 30, 2025 | -209,166.00 |
| Mar 31, 2025 | -40,161.00 |
| Dec 31, 2024 | -513,035.00 |
| Sep 30, 2024 | 215,217.00 |
| Jun 30, 2024 | -343,691.00 |
| Mar 31, 2024 | 75,901.00 |
| Dec 31, 2023 | 182,213.00 |
| Sep 30, 2023 | 52,586.00 |
| Jun 30, 2023 | 87,677.00 |
| Mar 31, 2023 | 46,270.00 |
| Dec 31, 2022 | 233,304.00 |